Lester J. Layfield, MDProfessor and ChairDepartment of Pathology & Anatomical SciencesUniversity of MissouriOne Hospital DriveM263 Medical Sciences BuildingColumbia, MO USAZubair W. Baloch, MD, PhD. Hospital of the University of Pennsylvania, Perelman School of Medicine.Department of Pathology & Laboratory MedicinePhiladelphia, PA USA

“All figures and tables are accompanied by useful legends. A very useful feature is the group of appendixes, which serves as a condensed version of the book and can be used for a quick lookup of criteria. As a book that aims to standardize respiratory cytology reporting, its ultimate success lies in the acceptance by practicing cytopathologists. … this book is a well‐written and much‐needed guideline from the Papanicolaou Society to further push for standardization of cytopathology reporting.” (Keluo Yao, Doody's Book Reviews, May 10, 2019)

• Overview of Diagnostic Terminology and Reporting.- Category I: Non-Diagnostic.- Category II: Negative (for Malignancy).- Category III: Atypical.- Category IV: Neoplastic: Benign.- Category IV: Neoplasm-Undetermined Malignant Potential.- Category V: Suspicious for Malignancy.- Category VI: Malignant.- Recommendations for Ancillary Testing.

Lester J. Layfield, MDProfessor and ChairDepartment of Pathology & Anatomical SciencesUniversity of MissouriOne Hospital DriveM263 Medical Sciences BuildingColumbia, MO USAZubair W. Baloch, MD, PhD. Hospital of the University of Pennsylvania, Perelman School of Medicine.Department of Pathology & Laboratory MedicinePhiladelphia, PA USA

“All figures and tables are accompanied by useful legends. A very useful feature is the group of appendixes, which serves as a condensed version of the book and can be used for a quick lookup of criteria. As a book that aims to standardize respiratory cytology reporting, its ultimate success lies in the acceptance by practicing cytopathologists. … this book is a well‐written and much‐needed guideline from the Papanicolaou Society to further push for standardization of cytopathology reporting.” (Keluo Yao, Doody's Book Reviews, May 10, 2019)

• Overview of Diagnostic Terminology and Reporting.- Category I: Non-Diagnostic.- Category II: Negative (for Malignancy).- Category III: Atypical.- Category IV: Neoplastic: Benign.- Category IV: Neoplasm-Undetermined Malignant Potential.- Category V: Suspicious for Malignancy.- Category VI: Malignant.- Recommendations for Ancillary Testing.

Lester J. Layfield, MDProfessor and ChairDepartment of Pathology & Anatomical SciencesUniversity of MissouriOne Hospital DriveM263 Medical Sciences BuildingColumbia, MO USAZubair W. Baloch, MD, PhD. Hospital of the University of Pennsylvania, Perelman School of Medicine.Department of Pathology & Laboratory MedicinePhiladelphia, PA USA

“All figures and tables are accompanied by useful legends. A very useful feature is the group of appendixes, which serves as a condensed version of the book and can be used for a quick lookup of criteria. As a book that aims to standardize respiratory cytology reporting, its ultimate success lies in the acceptance by practicing cytopathologists. … this book is a well‐written and much‐needed guideline from the Papanicolaou Society to further push for standardization of cytopathology reporting.” (Keluo Yao, Doody's Book Reviews, May 10, 2019)

• Overview of Diagnostic Terminology and Reporting.- Category I: Non-Diagnostic.- Category II: Negative (for Malignancy).- Category III: Atypical.- Category IV: Neoplastic: Benign.- Category IV: Neoplasm-Undetermined Malignant Potential.- Category V: Suspicious for Malignancy.- Category VI: Malignant.- Recommendations for Ancillary Testing.